| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Petco Health and Wellness Company, Inc. Class A Common Stock$2.52
+0.03 (+1.2%)
Market Cap
793.35 M
EPS
0.03
P/E Ratio
92.69 $
Value Trade
18.02 M
SEC Financials
Q4 2025Dilution Risk
Revenue
1.46 B
Total Assets
5.21 B
Total Liabilities
4.05 B
Equity
1.16 B
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
249.42 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
Dec 5, 2025
Overview
Volume
2.21 M
52 Week Range
2.24 - 4.51
% held by Insiders
47.37 %
% held by Institutions
53.4 %
Enterprise Value
3.39 B
Total Shares
243.24 M
Short %
21.86 %
Float Shares
83.19 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in WOOF
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Petco Health and Wellness Company, Inc. Class A Common Stock (WOOF) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
WOOF
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
WOOF
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
WOOF
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
WOOF Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
WOOF Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-09-18 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-WOOF
Jun 3, 2026Petco Reports First Quarter 2026 Results Returns to Positive Comp Growth in Q1, Validating ‘Reach for the Sky' Initiatives Delivers Q1 Sales and Profitability Ahead of Previously Provided Outlook Reaffirms Fiscal
Petco has reported its financial results for the first quarter of 2026, showcasing a return to positive comparable sales growth of 0.7%. This uptick validates the effectiveness of its 'Reach for the Sky' strategy, as the company experienced a 50.5% increase in operating income. However, it also noted an increased net loss for the quarter compared to the previous year, raising concerns about ongoing financial strain. The company reaffirmed its full-year outlook and provided insights into anticipated challenges in the upcoming quarter, particularly with tariffs and costs.
Read more →-WOOF
Mar 11, 2026Petco Reports Fourth Quarter and Full Year 2025 Results Delivers Profitability Ahead of Outlook, Reduces Leverage Ratio Provides Fiscal 2026 Outlook* San Diego
Petco reported its fourth quarter and full year 2025 results, showcasing improved profitability and strengthened financial metrics. The company exceeded its profitability goals and reduced its leverage ratio significantly, demonstrating effective management and operational improvements. However, net sales decreased slightly, indicating potential challenges in market demand. Looking ahead, Petco provided an optimistic outlook for fiscal 2026, emphasizing growth opportunities and expectations for positive comparable sales.
Read more →-WOOF
Feb 2, 2026Petco Announces Completion of Refinancing and Glenn Murphy's Transition to Chairman
Petco has announced the successful closing of its long-term debt refinancing and the transition of Glenn Murphy to Chairman of the Board, effective February 1. CEO Joel Anderson praised Murphy's leadership during a transformative period for the company, highlighting improvements in profitability and cash flow. The refinancing is expected to provide greater financial flexibility and support Petco's goals for sustainable growth. However, the company faces risks including increased competition and economic pressures that may affect future performance.
Read more →-WOOF
Jan 22, 2026Petco Announces Pricing of its $600,000,000 Offering of Senior Secured Notes
Petco has announced the pricing of $600 million in senior secured notes due on February 1, 2031, with an interest rate of 8.250%. The company plans to use the net proceeds to repay its existing term loan and for general corporate purposes. This refinancing effort could enhance financial stability, although the notes will not be registered under U.S. securities laws, limiting their sale. The completion of the offering is dependent on customary closing conditions.
Read more →-WOOF
Jan 21, 2026Petco Announces $650,000,000 Offering of Senior Secured Notes
Petco has announced an offering of $650 million in senior secured notes to be utilized for repaying existing debt and fulfilling corporate needs. The offering is contingent on customary closing conditions and will be guaranteed by its subsidiaries. Notably, these notes are secured against Petco's fixed and current assets, positioning them effectively senior to any unsecured debt. However, the offering's conditions and regulatory constraints could pose challenges ahead.
Read more →-WOOF
Jan 12, 2026Petco Announces Launch of Debt Refinancing Transaction; Reaffirms Fourth Quarter and Full Fiscal Year 2025 Outlook
Petco has announced a debt refinancing transaction aimed at extending loan maturities while reaffirming its guidance for the fourth quarter and full fiscal year 2025, which ends January 31, 2026. The company plans to refinance $1.5 billion of its outstanding term loan and recently made a $50 million voluntary prepayment. Despite reaffirming its financial outlook, Petco expects a decline in net sales. CEO Joel Anderson attributes the company's performance to the hard work of its nearly 30,000 team members.
Read more →-WOOF
Nov 25, 2025Petco Reports Third Quarter 2025 Financial Results Upwardly Revises Fiscal 2025 Earnings Outlook* San Diego
Petco announced its Q3 2025 financial results, reporting a 3.1% decrease in net sales year over year, with comparable sales down 2.2%. Despite these declines, the company saw improvements in operating income, gross profit margin, and GAAP net income. Additionally, Petco has upwardly revised its fiscal 2025 earnings guidance and expects continued profitability as it focuses on restructuring for future growth. The company’s outlook remains cautious, with projections of net sales decline for the full year 2025.
Read more →-WOOF
Aug 28, 2025Petco Reports Second Quarter 2025 Financial Results Raises Fiscal 2025 Earnings Outlook* San Diego
Petco has reported its second quarter financial results for 2025, revealing a net sales decline of 2.3% year over year but an increase in both gross profit margin and operating income. The company raised its earnings outlook for the full year, citing effective cost management and improved retail fundamentals. However, with comparable sales also down by 1.4%, Petco indicates challenges ahead, particularly concerning the impact of tariffs and the potential for store closures. Despite these hurdles, the management remains optimistic about its strategic investments aimed at sustainable growth.
Read more →-WOOF
Aug 21, 2025Petco to Present at Goldman Sachs Global Retailing Conference on
Petco (Nasdaq: WOOF) has announced its participation in the 32nd Annual Goldman Sachs Global Retailing Conference on September 4, 2025. The presentation is set to take place at approximately 1:50 p.m. Eastern Time and will be available via live webcast. The company highlighted its commitment to pet care and animal welfare, noting its support for local animal welfare groups and enhancing the pet-human bond through its products and services available across various platforms.
Read more →-WOOF
Jun 5, 2025Investor Relations Media Relations Tina Romani Lisa Stark investorrelations@petco.com Lisa.stark@petco.com FOR IMMEDIATE RELEASE
Petco Health and Wellness Company, Inc. has released its financial results for the first quarter of 2025, reporting a net sales of $1.5 billion, a decrease of 2.3% compared to the previous year. Despite this decline in sales, the company improved its operating income and gross profit margin. Petco reaffirmed its outlook for fiscal 2025, including expectations for adjusted EBITDA and net sales to decline slightly. The management expressed confidence in their strategic efforts and adaptability in the current market landscape.
Read more →-WOOF
Feb 18, 2025PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES Sabrina Simmons Appointed Chief Financial Officer Michael Romanko Appointed Chief Customer and Product Officer Jack Stout Appointed Chief Merc
Petco has announced the addition of three experienced executives to its leadership team, aiming for improved operational efficiency and a swift return to profitable growth. Sabrina Simmons steps in as Chief Financial Officer, Michael Romanko as Chief Customer and Product Officer, and Jack Stout as Chief Merchandising Officer. These appointments follow previous executive hires and reflect Petco's ongoing commitment to enhancing its operational strategy. The new leaders bring substantial industry experience to help drive the company's objectives through 2025.
Read more →-WOOF
Dec 5, 2024Investor Relations investorrelations@petco.com Media Relations Lisa.stark@petco.com FOR IMMEDIATE RELEASE
Petco Health + Wellness Company, Inc. has reported its Q3 2024 earnings, highlighting a 1.2% increase in net revenue to $1.51 billion. Although the company achieved a significant reduction in net loss compared to the previous year, challenges remain as their supplies and companion animal business reported a decline. Optimistic indicators include an increase in gross profit and adjusted EBITDA, reinforcing the company's commitment to improving retail fundamentals and driving sustainable growth. Petco's Q4 guidance includes expected revenue of approximately $1.55 billion and a positive adjust EBITDA outlook.
Read more →-WOOF
Sep 10, 2024Investor Relations investorrelations@petco.com Media Relations Benjamin Thiele-Long benjamin.thiele-long@petco.com FOR IMMEDIATE RELEASE
Petco Health and Wellness Company, Inc. reported its second quarter 2024 financial results with a net revenue of $1.52 billion, a decrease of 0.5% year-over-year. The company's GAAP net loss stood at $24.8 million, up from a loss of $14.6 million in the prior year. However, Petco experienced a 0.3% increase in comparable sales, with growth in its consumables and services segments. The earnings outlook for Q3 2024 anticipates net revenue to be around $1.5 billion with an adjusted EBITDA expected between $76 million to $80 million.
Read more →-WOOF
Jul 17, 2024Petco Names Joel D. Anderson as Chief Executive Officer 30-Year Retail Industry Veteran Named Chief Executive Officer and Member of the Board of Directors R. Michael Mohan to Lead a New Board Committee Focused on Value C
Petco Health and Wellness Company, Inc. has appointed Joel D. Anderson as its new Chief Executive Officer and a member of the Board of Directors, effective July 29, 2024. Anderson, who has over 30 years of experience in the retail industry, is expected to lead initiatives aimed at improving the company’s operating and financial results. Concurrently, R. Michael Mohan will transition to chair a new Board committee focused on value creation, following his interim role as CEO. The Board expressed confidence in Anderson's ability to enhance shareholder value and create a stronger future for Petco.
Read more →-WOOF
May 28, 2024Petco Health + Wellness Company, Inc. Announces Evolution of Leadership Team Appoints James Roth as Chief Stores Officer Appoints Shari White as Interim Chief Merchant
Petco Health + Wellness Company, Inc. has announced significant changes to its leadership team, appointing James Roth as Chief Stores Officer and Shari White as Interim Chief Merchant. These changes aim to simplify decision-making and enhance operational efficiency as part of the company's strategic initiatives. The appointment of Roth is expected to improve operational leadership across Petco's locations, while the company conducts a search for a permanent Chief Merchant. The elimination of the Chief Operating Officer role and the upcoming departure of Amy College raise questions about stability within the team.
Read more →-WOOF
May 22, 2024Investor Relations Media Relations investorrelations@petco.com Benjamin Thiele-Long benjamin.thiele-long@petco.com FOR IMMEDIATE RELEASE
Petco Health + Wellness Company, Inc. reported its first quarter 2024 earnings, showing a net revenue decrease of 1.7% year over year to $1.5 billion. The company experienced a GAAP net loss of $46.5 million, a significant increase from the previous year's loss. Despite some growth in the consumables and services segments, overall performance was impacted by declines in other areas. The interim CEO is optimistic about future profitability through strategic adjustments and a focus on core retail operations.
Read more →-WOOF
May 14, 2024Petco Health + Wellness Company, Inc. Announces Appointment of Glenn Murphy as Executive Chairman of the Board of Directors Murphy to support leadership team s initiatives to improve profitability and drive long-term gro
Petco Health + Wellness Company, Inc. has appointed Glenn Murphy as the Executive Chairman of its Board of Directors, effective immediately. Murphy is expected to support the leadership team in enhancing profitability and driving long-term growth. His extensive experience in retail, including prior leadership roles at lululemon and Gap, positions him well to navigate this transition. Murphy's appointment comes with significant equity stakes and inducement awards, aiming to align his objectives with Petco's growth strategies.
Read more →-WOOF
Mar 13, 2024Investor Relations Cathy Yao cathy.yao@petco.com Media Relations Benjamin Thiele-Long benjamin.thiele-long@petco.com FOR IMMEDIATE RELEASE
Petco Health + Wellness Company, Inc. announced its financial results for the fourth quarter and full year 2023, showing a mixed performance. While net revenue increased by 6.1% in Q4 and 3.6% for the year, the company reported significant losses, including a GAAP net loss of $1.3 billion attributable largely to goodwill impairment. In contrast, growth in both the consumables and services segments was noted, but declines in the supplies and companion animal business posed challenges. Due to leadership changes, guidance for full year 2024 metrics is not currently provided, adding uncertainty.
Read more →-WOOF
Feb 26, 2024Petco to Participate in the UBS Global Consumer and Retail Conference
Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) announced that CFO Brian LaRose will participate in the UBS Global Consumer and Retail Conference on March 14, 2024. The conversation will offer insights into the company's financial strategy and vision. Interested parties can access the live webcast and a replay through Petco's investor relations page. Petco, founded in 1965, continues to define the pet health and wellness category with its extensive network and community involvement.
Read more →-WOOF
Sep 15, 2023Investor Relations Media Relations Cathy Yao Benjamin Thiele-Long cathy.yao@petco.com benjamin.thiele-long@petco.com FOR IMMEDIATE RELEASE
Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) has announced its participation in the Evercore ISI Virtual Pet Care Summit scheduled for September 20, 2023. Chief Financial Officer Brian LaRose and Chief Veterinarian Dr. Whitney Miller will represent the company in a fireside conversation and a panel discussion, respectively. The events aim to highlight Petco's focus on pet care services and its ongoing commitment to improving pet wellness. Interested parties can access the event webcast via the company’s investor relations page.
Read more →-WOOF
May 24, 2023Petco Health + Wellness Company, Inc.
Petco Health + Wellness Company, Inc. reported its first quarter 2023 financial results, highlighting a net revenue of $1.56 billion, a 5.4% increase compared to the previous year. However, the company experienced a net loss of $1.9 million, a significant drop from the net income of $24.7 million reported in the same quarter last year. The report noted an 18th consecutive quarter of comparable sales growth, driven primarily by the company's consumables business. Despite the challenges reflected in decreased adjusted EBITDA and operating cash flow, Petco reaffirmed its full year guidance for 2023.
Read more →-WOOF
Jan 4, 2023Petco to Participate in the 25 th Annual Needham Growth Conference
Petco Health and Wellness Company, Inc. announced its participation in the 25th Annual Needham Growth Conference, scheduled for January 11, 2023. The event will include a fireside chat aimed at discussing the company's strategic initiatives and growth prospects. The conference will be accessible to investors through a live audio webcast, which will later be archived on Petco's website. Petco emphasizes its focus on improving the lives of pets and pet parents through various wellness products and services.
Read more →-WOOF
Dec 2, 2022Petco Updates Time for Participation in Morgan Stanley Global Consumer & Retail Conference
Petco Updates Time for Participation in Morgan Stanley Global Consumer & Retail Conference SAN DIEGO, Dec. 2, 2022 /PRNewswire/ Petco Health and Wellness Company, Inc. (the Company or Petco ) (Nasdaq: WOOF) today announced that the Company will participate in a fireside chat at
Read more →-WOOF
Dec 1, 2022Petco to Participate in the Morgan Stanley Global Consumer & Retail Conference
Petco to Participate in the Morgan Stanley Global Consumer & Retail Conference SAN DIEGO, Dec. 1, 2022 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (the Company or Petco ) (Nasdaq: WOOF) today announced that the Company will participate in a fireside chat at the Morga
Read more →-WOOF
Nov 30, 2022Petco Health + Wellness Company, Inc. Reports Third Quarter Earnings • Comparable sales grew 4.1 percent year over year and 19.6 percent on a two-year basis, resulting in sixteenth consecutive quarter of comparabl
Petco Health + Wellness Company, Inc. Reports Third Quarter Earnings -Comparable sales grew 4.1 percent year over year and 19.6 percent on a two-year basis, resulting in sixteenth consecutive quarter of comparable sales growth -Net revenue of $1.50 billion increased 4.0 percent
Read more →-WOOF
Sep 6, 2022Petco to Present at Goldman Sachs 29 th Annual Global Retailing Conference
Petco to Present at Goldman Sachs 29th Annual Global Retailing Conference SAN DIEGO, Sept. 6, 2022 / PRNewsire / -- Petco Health and Wellness Company, Inc. (the "Company" or "Petco") (Nasdaq: WOOF) today announced that the Company will present at the Goldman Sachs 29th Annual Gl
Read more →-WOOF
Aug 9, 2022Petco evolves organizational design to enable next phase of growth
Petco evolves organizational design to enable next phase of growth SAN DIEGO, August 9, 2022 Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced an evolution in its organizational design and new roles to enable continued growth by fully leveraging its end-to-
Read more →-WOOF
May 24, 2022Investor Relations Media Relations investorrelations@petco.com Benjamin Thiele-Long benjamin.thiele- long@petco.com FOR IMMEDIATE RELEASE
Contacts: Investor Relations Media Relations investorrelations@petco.com Benjamin Thiele-Long benjamin.thiele- long@petco.com FOR IMMEDIATE RELEASE: May 24, 2022 Petco Health + Wellness Company, Inc. Reports First Quarter Earnings San Diego, May 24, 2022 Petco Health a
Read more →-WOOF
Mar 23, 2022Petco Health + Wellness Company, Inc. Announces Long-Term Strategic Priorities as it Shapes the Future of Pet Health and Wellness Outlines strategic approach to drive sustained, profitable growth with industry-leading ec
Petco Health + Wellness Company, Inc. Announces Long-Term Strategic Priorities as it Shapes the Future of Pet Health and Wellness SAN DIEGO, March 23, 2022 Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, is hosting its 202
Read more →-WOOF
Mar 8, 2022Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com FOR IMMEDIATE RELEASE
Contacts: Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com FOR IMMEDIATE RELEASE: March 8, 2022 Petco Health + Wellness Company, Inc. Reports Record Year of Revenue and Profitability, Issues 2022 Guidance San
Read more →-WOOF
Mar 2, 2022Petco Health and Wellness Company, Inc. to Host Inaugural Investor Day on
Petco Health and Wellness Company, Inc. to Host Inaugural Investor Day on March 23, 2022 SAN DIEGO, March 2, 2022 On March 23, 2022, at approximately 8 a.m. Eastern Standard Time, Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), will hold its 2022 Investor Day. This even
Read more →-WOOF
Mar 1, 2022Petco the Retail Leader in Premium Fresh Frozen Expands Unique Partnership with JustFoodForDogs to Meet Growing Pet Parent Demand and Capture Multi-Billion Dollar Market Opportunity Petco to launch new Owned Brand fresh
Petco the Retail Leader in Premium Fresh Frozen Expands Unique Partnership with JustFoodForDogs to Meet Growing Pet Parent Demand and Capture Multi-Billion Dollar Market Opportunity SAN DIEGO, March 1, 2022 Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced
Read more →-WOOF
Dec 6, 2021Petco Appoints Digital, Strategy Leader Iris Yen as Board Advisor and Observer
Petco Appoints Digital, Strategy Leader Iris Yen as Board Advisor and Observer SAN DIEGO, Dec. 6, 2021 Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), today announced the appointment of Iris Yen as an Advisor to its Board of Directors. As part of her appointment, Ms. Ye
Read more →-WOOF
Dec 6, 2021Media Relations Investor Relations Ventura Olvera Kristy Moser Ventura.olvera@petco.com Kristine.moser@petco.com Petco to Present at Citi Global Consumer Conference 2021
Contacts: Media Relations Investor Relations Ventura Olvera Kristy Moser Ventura.olvera@petco.com Kristine.moser@petco.com Petco to Present at Citi Global Consumer Conference 2021 SAN DIEGO, Dec. 6, 2021 Petco Health and Wellness Company, Inc. (the Company or Petco ) (Nasd
Read more →-WOOF
Nov 19, 2021Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at 1st Annual Needham Virtual Consumer Tech / E-Commerce Conference
Contacts: Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at 1st Annual Needham Virtual Consumer Tech / E-Commerce SAN DIEGO, November 19, 2021 / PRNewswire / Petco Health and Wellness Compan
Read more →-WOOF
Nov 18, 2021Investor Relations Kristy Moser Kristine.moser@petco.com Media Relations Ventura Olvera Ventura.olvera@petco.com FOR IMMEDIATE RELEASE
FOR IMMEDIATE RELEASE: November 18, 2021 Petco Health + Wellness Company, Inc. announces record revenue and earnings with 15 percent comp growth and a 32 percent two-year comp San Diego, November 18, 2021 Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partne
Read more →-WOOF
Sep 15, 2021Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at Jefferies Virtual Pet Care Summit
Contacts: Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at Jefferies Virtual Pet Care Summit SAN DIEGO, September 15, 2021 / PRNewswire / Petco Health and Wellness Company, Inc. (the Compan
Read more →-WOOF
Sep 8, 2021Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at Goldman Sachs 28 th Annual Global Retailing Conference
Contacts: Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at Goldman Sachs 28th Annual Global Retailing SAN DIEGO, September 8, 2021 / PRNewswire / Petco Health and Wellness Company, Inc. (th
Read more →-WOOF
Aug 19, 2021Petco Health and Wellness Company, Inc. Appoints Brian LaRose as Chief Financial Officer LaRose succeeds Mike Nuzzo who continues in his role as Chief Operating Officer and President, Petco Services
Petco Health and Wellness Company, Inc. Appoints Brian LaRose as Chief Financial Officer LaRose succeeds Mike Nuzzo who continues in his role as Chief Operating Officer and President, Petco Services SAN DIEGO, Aug. 19, 2021 Petco Health and Wellness Company, Inc. (Nasdaq: WOOF)
Read more →-WOOF
Jun 14, 2021Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at Evercore ISI Consumer & Retail Summit
Contacts: Investor Relations Media Relations Kristy Moser Ventura Olvera Kristine.moser@petco.com Ventura.olvera@petco.com Petco to Present at Evercore ISI Consumer & Retail Summit SAN DIEGO, June 14, 2021 / PRNewswire / Petco Health and Wellness Company, Inc. (the
Read more →-WOOF
Jun 9, 2021Investor Relations Kristy Moser Kristine.moser@petco.com Media Relations Ventura Olvera Ventura.olvera@petco.com Petco to Present at the Baird 2021 Global Consumer, Technology & Services Conference
Petco to Present at the Baird 2021 Global Consumer, Technology & Services Conference SAN DIEGO, June 9, 2021 / PRNewswire / Petco Health and Wellness Company, Inc. (the Company or Petco ) (NASDAQ: WOOF) today announced that the Company will present virtually at the Baird 2021 G
Read more →-WOOF
Mar 5, 2021Petco Announces Successful Completion of Debt Refinancing Transaction, Solidifying its Capital Position and Enhancing Financial Flexibility Refinancing follows public listing in January 2021 and is the late
Petco Announces Successful Completion of Debt Refinancing Transaction, Solidifying its Capital Position and Enhancing Financial Flexibility Refinancing follows public listing in January 2021 and is the latest step in Petco s continued transformation SAN DIEGO, March 5, 2021 Pe
Read more →Competitive Position
How WOOF ranks across every disease it competes inCompetitive Position is a premium feature
See how WOOF ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial